Assessment of p53 mutations, expression and prognosis in bladder cancer patients from Jordan: Identification of novel deletion mutations in the DNA-binding domain-Reference-Cited by-同舟云学术

Assessment of p53 mutations, expression and prognosis in bladder cancer patients from Jordan: Identification of novel deletion mutations in the DNA-binding domain

Published:2017-06 Issue: Volume:12 Page:33-42
ISSN:2214-5400
Container-title:Meta Gene
language:en
Short-container-title:Meta Gene

Author:

Bodoor Khaldon,Al-Ghabkari Abdulhameed,Matalka Ismail,Haddad Yazan,Alkhateeb Asem,Jaradat Saied,Jaradat Ziad W,Al-Ghazo Mohammed,Abu-sheikha Aya,Jalboush Sara Abu,Jarun Yousef

Funder

Arab Science and Technology Foundation

Publisher

Elsevier BV

Subject

Genetics (clinical),Genetics

Reference60 articles.

1. Specific-mutational patterns of p53 gene in bladder transitional cell carcinoma among a group of Iraqi patients exposed to war environmental hazards;Al-Kashwan;BMC Res Notes,2012

2. FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder;Bakkar;Cancer Res.,2003

3. p53 mutations in urinary bladder cancer;Berggren;Br. J. Cancer,2001

4. FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population;Bodoor;Cancer Epidemiol.,2010

5. Urothelial papillary (exophytic) neoplasms;Bostwick;Virchows Arch.,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Fibroblast Growth Factor Receptor 3 (FGFR3) and Tumor Protein P53 (TP53) as Independent Prognostic Biomarkers in High-Grade Non-muscle Invasive Bladder Cancer;Cureus;2024-07-31

2. Prognostic value of a panel of immunohistochemical markers for determining the risk of recurrence and progression of non-invasive bladder cancer;Український радіологічний та онкологічний журнал;2023-12-29

3. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression;Journal of Experimental & Clinical Cancer Research;2019-10-29